Monday, July 13, 2026
Facebook Linkedin Twitter
HomeIndustriesHealthcare

Healthcare

Biotechnology

Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results

PR Newswire -
The Janssen Pharmaceutical Companies of Johnson & Johnson announced new analyses from the Phase 3 MAIA study of DARZALEX in combination with lenalidomide and...
Healthcare

Karyopharm Announces Presentation of Updated Phase 1 Selinexor Data in Patients

PR Newswire -
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced updated results from the Phase 1 portion of its study evaluating the...
Healthcare

Pennsylvania-based Highmark Inc. Joins Theranica’s Coverage with Evidence Program

PR Newswire -
Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, announced that Highmark Inc. (Highmark), one of America's...
Healthcare

Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy

PR Newswire -
Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, announced...
Biotechnology

Body of Evidence Grows From ZUMA-7 Study Supporting Initial Treatment

Business Wire -
Kite, a Gilead Company announced findings from two new analyses of the landmark ZUMA-7 trial of Yescarta, the largest and longest follow-up of a...
1...248249250...565Page 249 of 565

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us | Terms & Conditions